These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7672927)

  • 1. [Comments on the contribution by Prof. Dr. S. H. Hohnloser. Sotalol].
    Bode-Böger SM; Böger RH; Frölich JC
    Internist (Berl); 1995 Jul; 36(7):744. PubMed ID: 7672927
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia.
    Saul JP; Ross B; Schaffer MS; Beerman L; Melikian AP; Shi J; Williams J; Barbey JT; Jin J; Hinderling PH;
    Clin Pharmacol Ther; 2001 Mar; 69(3):145-57. PubMed ID: 11240979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia.
    Shi J; Ludden TM; Melikian AP; Gastonguay MR; Hinderling PH
    J Pharmacokinet Pharmacodyn; 2001 Dec; 28(6):555-75. PubMed ID: 11999292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia.
    Läer S; Elshoff JP; Meibohm B; Weil J; Mir TS; Zhang W; Hulpke-Wette M
    J Am Coll Cardiol; 2005 Oct; 46(7):1322-30. PubMed ID: 16198851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sotalol hydrochloride (Betapace): a new antiarrhythmic drug.
    Dunnington CS
    Am J Crit Care; 1993 Sep; 2(5):397-406. PubMed ID: 8220672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose sotalol in pediatric arrhythmia therapy.
    Rokicki W; Dukalska M
    Pediatr Cardiol; 1999; 20(2):172-3. PubMed ID: 9986903
    [No Abstract]   [Full Text] [Related]  

  • 7. Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia.
    Saul JP; Schaffer MS; Karpawich PP; Erickson CC; Epstein MR; Melikian AP; Shi J; Karara AH; Cai B; Hinderling PH
    J Clin Pharmacol; 2001 Jan; 41(1):35-43. PubMed ID: 11144992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sotalol].
    Hohnloser SH
    Internist (Berl); 1995 Feb; 36(2):170-3; discussion 174. PubMed ID: 7737808
    [No Abstract]   [Full Text] [Related]  

  • 9. Sotalol: a novel beta-blocker with class III anti-arrhythmic activity.
    Leibowitz D
    J Clin Pharmacol; 1993 Jun; 33(6):508-12. PubMed ID: 8366175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of sotalol on heart rate variability in patients with symptomatic, complex ventricular arrhythmias].
    Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Apr; 83(4):293-8. PubMed ID: 8023542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience with dl-sotalol in the treatment of supraventricular arrhythmia].
    Trabulo M; Almeida M; Caires G; Mesquita A; Parreira L; Morgado F; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1996 Oct; 15(10):725-9, 696. PubMed ID: 9115766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sotalol marketed for life-threatening arrhythmias.
    Clin Pharm; 1993 Mar; 12(3):176. PubMed ID: 8491074
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comments on the contribution by S. Klein et al. Cyclosporin A in therapy of chronic uveitis].
    Thurau SR; Lund OE; Bechtel U; Feucht HE
    Ophthalmologe; 1993 Jun; 90(3):294; author reply 295. PubMed ID: 8334335
    [No Abstract]   [Full Text] [Related]  

  • 14. Sotalol: a new class III antiarrhythmic agent.
    Zanetti LA
    Clin Pharm; 1993 Dec; 12(12):883-91. PubMed ID: 8137605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug therapy of supraventricular and ventricular tachyarrhythmias].
    Hohnloser SH
    Internist (Berl); 1996 Jan; 37(1):45-52. PubMed ID: 8837827
    [No Abstract]   [Full Text] [Related]  

  • 16. [Magnesium: current studies--critical evaluation--consequences].
    Meinertz T
    Z Kardiol; 1996; 85 Suppl 6():147-51. PubMed ID: 9064959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tachycardias: considerations in childhood in the 90s].
    Gutiérrez-Larraya F; Jabón A
    An Esp Pediatr; 1993 Dec; 39(6):475-88. PubMed ID: 8166400
    [No Abstract]   [Full Text] [Related]  

  • 18. [Protocols for the treatment of supraventricular tachycardias in the fetus].
    Oudijk MA; Ambachtsheer EB; Stoutenbeek P; Meijboom EJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(25):1218-9. PubMed ID: 11447879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brazilian multicenter study of sotalol effectiveness in ventricular arrhythmias].
    Maia IG; Lorga AM; de Paola AA; Rassi A; Perez AK; Sobral D; Atie J; Gizzi JC; Darwich R
    Arq Bras Cardiol; 1996 Mar; 66(3):173-8. PubMed ID: 8762699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procainamide: a perspective on its value and danger.
    Ellenbogen KA; Wood MA; Stambler BS
    Heart Dis Stroke; 1993; 2(6):473-6. PubMed ID: 8137053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.